ATR inhibition induces synthetic lethality and overcomes chemoresistance in TP53- or ATM-defective chronic lymphocytic leukemia cells (vol 127, pg 582, 2016)

Kwok M.; Davies N.; Agathanggelou A.

首页> 外文期刊>Blood: The Journal of the American Society of Hematology >ATR inhibition induces synthetic lethality and overcomes chemoresistance in TP53- or ATM-defective chronic lymphocytic leukemia cells (vol 127, pg 582, 2016)

【24h】

ATR inhibition induces synthetic lethality and overcomes chemoresistance in TP53- or ATM-defective chronic lymphocytic leukemia cells (vol 127, pg 582, 2016)

机译：抑制ATR可以诱导合成杀伤力并克服TP53或ATM缺陷型慢性淋巴细胞白血病细胞的化学耐药性（第127卷，第582页，2016年）

获取原文

获取原文并翻译 | 示例

获取外文期刊封面封底 >>

开具论文收录证明 >>

文献代查 >>

团队文献服务 >>

页面导航

著录项
引文网络
相似文献
相关主题

著录项

来源
《Blood: The Journal of the American Society of Hematology》 |2016年第21期|共1页
作者
Kwok M.; Davies N.; Agathanggelou A.;
展开▼
作者单位

展开▼
收录信息
原文格式 PDF
正文语种 eng
中图分类
关键词

相似文献

外文文献
中文文献
专利

1. ATR inhibition induces synthetic lethality and overcomes chemoresistance in TP53- or ATM-defective chronic lymphocytic leukemia cells (vol 127, pg 582, 2016) [J] . Kwok M., Davies N., Agathanggelou A. Blood: The Journal of the American Society of Hematology . 2016,第21期

机译：抑制ATR可以诱导合成杀伤力并克服TP53或ATM缺陷型慢性淋巴细胞白血病细胞的化学耐药性（第127卷，第582页，2016年）
2. Inhibition of NF-κB-mediated signaling by the cyclin-dependent kinase inhibitor CR8 overcomes prosurvival stimuli to induce apoptosis in chronic lymphocytic leukemia cells [J] . CosimoE., McCaigA.M., Carter-BrzezinskiL.J.M., Clinical cancer research: an official journal of the American Association for Cancer Research . 2013,第9期

机译：细胞周期蛋白依赖性激酶抑制剂CR8对NF-κB介导信号的抑制作用克服了生存刺激，从而诱导了慢性淋巴细胞白血病细胞的凋亡
3. Inhibition of Aurora A Kinase in Combination with Chemotherapy Induces Synthetic Lethality and Overcomes Chemoresistance in Myc-Overexpressing Lymphoma [J] . Park Steven I., Lin Carolina P., Ren Natalie, Targeted oncology . 2019,第5期

机译：抑制Aurora激酶与化疗组合诱导合成致死率，克服Myc过表达淋巴瘤中的化学性
4. Detection of de novo IGHV mutations by ultra-deep sequencing from in vitro activated B-cell chronic lymphocytic leukemia cells: Evidence for activation-induced deaminase function [C] . Chu C.C., Patten P.E.M., MacCarthy T, International Congress of Immunology. . 2014

机译：通过来自体外活化B细胞慢性淋巴细胞白血病细胞超深序的De Novo IghV突变检测：活化诱导的脱氨酶功能的证据
5. Molecular and cellular determinants of lymph node microenvironment-induced immunosuppression in chronic lymphocytic leukemia. [D] . Cutucache, Christine E. 2012

机译：慢性淋巴细胞白血病中淋巴结微环境诱导的免疫抑制的分子和细胞决定因素。
6. Dual SYK/JAK inhibition overcomes ibrutinib resistance in chronic lymphocytic leukemia: Cerdulatinib but not ibrutinib induces apoptosis of tumor cells protected by the microenvironment [O] . Ailin Guo, Pin Lu, Greg Coffey, 2017

机译：双重SYK / JAK抑制作用克服了慢性淋巴细胞白血病中的依鲁替尼耐药性：Cerdulatinib而非ibrutinib诱导微环境保护的肿瘤细胞凋亡
7. ATR inhibition induces synthetic lethality and overcomes chemoresistance in TP53- or ATM-defective chronic lymphocytic leukemia cells. [O] . Kwok, Marwan, Davies, Nicholas, Agathanggelou, Angelo, 2016

机译：ATR抑制可诱导合成杀伤力并克服TP53或ATM缺陷型慢性淋巴细胞白血病细胞的化学耐药性。

ATR inhibition induces synthetic lethality and overcomes chemoresistance in TP53- or ATM-defective chronic lymphocytic leukemia cells (vol 127, pg 582, 2016)

著录项

引文网络

相似文献

相关主题

期刊订阅